Atorvastatin cuts anthracycline heart failure

Published Date: 08 Mar 2023

Atorvastatin 40 mg daily for 12 months reduces cardiovascular events in lymphoma patients treated with anthracyclines.

Read Full News

Latest News

AI's 'Blind Trust' Problem Puts Patients at Risk

Panelists at HLTH Europe 2026 warned that clinicians and patients are increasingly deferring to algorithmic outputs over independent judgment.

Closing the Women's Health Gap With AI and Better Data

From cardiac misdiagnosis to an 8-year wait for endometriosis, experts at HLTH Europe lay out how AI and multimodal data can start closing the gender health gap.

Protein and Creatine Supplements Are No Longer Niche

The fitness supplements have gone mainstream. How much is too much? How should GLP-1 patients use them? Will creatine save our brains? Here’s what the science says.

GLP-1s Tied to Higher Risk for Dizziness, Fainting for Some

Hypotension-related events increased after starting GLP-1s in patients taking multiple antihypertensive medications.

Phase 3 HCM Drug Offers Promising Results in Exercise Tests

Treatment with aficamten may improve multiple measures of exercise in patients with obstructive hypertrophic cardiomyopathy, a study finds.

GLP-1 Therapy: Can a Myostatin Antibody Preserve Muscle?

A phase 2 trial suggests myostatin inhibition may reduce lean body mass loss during tirzepatide treatment while maintaining overall weight reduction.

Todays Updates

Dostarlimab Boosts Long-Term Survival in Endometrial Cancer

At 4 years, dostarlimab plus chemotherapy reduced the risk for death by two thirds among patients with dMMR/MSI-H advanced endometrial cancer, pointing to curative potential, experts say.

Todays Updates

Dostarlimab Boosts Long-Term Survival in Endometrial Cancer

At 4 years, dostarlimab plus chemotherapy reduced the risk for death by two thirds among patients with dMMR/MSI-H advanced endometrial cancer, pointing to curative potential, experts say.

Latest News

Panelists at HLTH Europe 2026 warned that clinicians and patients are increasingly deferring to algorithmic outputs over independent judgment.

From cardiac misdiagnosis to an 8-year wait for endometriosis, experts at HLTH Europe lay out how AI and multimodal data can start closing the gender health gap.

The fitness supplements have gone mainstream. How much is too much? How should GLP-1 patients use them? Will creatine save our brains? Here’s what the science says.

Hypotension-related events increased after starting GLP-1s in patients taking multiple antihypertensive medications.

Treatment with aficamten may improve multiple measures of exercise in patients with obstructive hypertrophic cardiomyopathy, a study finds.

A phase 2 trial suggests myostatin inhibition may reduce lean body mass loss during tirzepatide treatment while maintaining overall weight reduction.

News All Time

Left Main CAD: Can New 10-Year Data Settle the Debate?

Ten-year follow-up data show similar mortality with PCI and CABG in selected patients, adding new evidence to the long-standing revascularization debate.

Could Dedicated Women’s Heart Centers Close Care Gaps?

Experts call for more women’s Heart Centers across Europe, citing persistent disparities in cardiovascular diagnosis, treatment, and outcomes.

Med Op-Ed: Dying of Old Age, Gambling Screening, and More

A leading cause of death in Japan does not follow global medical conventions; why primary care clinicians should screen for gambling disorder; and a trial refutes vitamin C as a treatment for severe burns.

What Anxiety and Depression Signal in Atrial Fibrillation

Anxiety and depression are linked to a higher risk for death and major adverse cardiovascular events, with a greater risk at higher symptom severity, prompting closer attention in routine care.

Finerenone May Cut Sudden Death Risk Across the CKM Spectrum

Finerenone treatment is associated with a reduced risk for sudden death among adults with chronic kidney disease, type 2 diabetes, or heart failure, study finds.

The Evolving Landscape of Sickle Cell Disease Treatment

Gene therapy and small molecules are opening the door to new curative approaches, but access continues to be a barrier for most patients.

Which Factors Affect Heart Health in Indigenous Canadians?

Unconventional research highlights the need for models of cardiac care that combine Indigenous and Western knowledge systems.

Alcohol-Induced Deaths: Australian Experts Call for Support

Deaths from alcohol show no sign of declining, and some experts are calling for stronger regulation of alcohol advertising and more specialist services to meet demand.

Patients on GLP-1s: Drugs Aren’t a ‘Magic Bullet’

GLP-1s aren’t a miracle weight-loss solution but a tool that facilitates behavior change and that comes with some significant downsides, the drugs’ users tell researchers.

Can AI Match Physicians’ Judgment, Not Just Diagnosis?

Studies show that AI increasingly matches or exceeds physicians on select diagnostic tasks, yet experts stress that clinical judgment remains essential.

Low Lp(a) Not Linked to Most Safety Risks in ASCVD Patients

Low levels of lipoprotein(a) are not linked to most safety risks, except for a modest increase in the risk for diabetes, a study finds.

App May Help Reduce Same-Day Cardioversion Cancellations

Smartphone-based monitoring of heart rhythm before cardioversion may help reduce same-day cancellations and detect spontaneous changes in heart rhythm in patients with atrial fibrillation or flutter.

Bad Bunny Joins the CPR Playlist

From Bad Bunny to Celia Cruz, music is being used to teach CPR rhythm, and experts say the right beat may help rescuers stay on pace.

Does Lenvatinib Plus Nivolumab Extend Survival in HCC?

The combination of lenvatinib and nivolumab may enhance survival outcomes in patients with unresectable advanced hepatocellular carcinoma, a single-arm trial reports.

JAK Inhibitors Effective in RA, Safer With Risk-Based Use

JAK inhibitors show effectiveness and persistence in routine care of adults with rheumatoid arthritis, and cautious patient selection under new recommendations is linked to safer outcomes.

Migraine With Aura Tied to Higher Stroke Risk

Migraine with aura is associated with an increased risk for ischemic stroke in middle-aged and older adults, particularly men younger than 72 years, a new study shows.